Bank Julius Baer & Co
FATE icon

Bank Julius Baer & Co’s Fate Therapeutics FATE Stock Holding History

Bank Julius Baer & Co’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-280
Closed -$1K – 532
2023
Q2 		$1K Hold
280
– – ﹤0.01% 557
2023
Q1 		$2K Hold
280
– – ﹤0.01% 581
2022
Q4 		$3K Sell
280
-9,106
-97% -$171K ﹤0.01% 566
2022
Q3 		$210K Sell
9,386
-3,742
-29% -$108K ﹤0.01% 398
2022
Q2 		$325K Sell
13,128
-6,022
-31% -$166K ﹤0.01% 370
2022
Q1 		$742K Buy
19,150
+437
+2% +$16.9K ﹤0.01% 312
2021
Q4 		$1.09M Buy
+18,713
New +$1.06M 0.01% 337

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank Julius Baer & Co's FATE Position: Q3 2023 in Review

Bank Julius Baer & Co sold out of Fate Therapeutics (FATE) in Q3 2023, closing a stake of 280 shares — an estimated $1K sold.

Bank Julius Baer & Co first reported a position in FATE in Q4 2021 and held it in 7 quarters. The position peaked at $1.09M in Q4 2021. 170 funds tracked by Wall St. Rank hold FATE as of Q3 2023.

  • Bank Julius Baer & Co reported no remaining Fate Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Bank Julius Baer & Co sold 280 Fate Therapeutics shares in Q3 2023, an estimated $1K.
  • Bank Julius Baer & Co first reported a position in Fate Therapeutics in Q4 2021 and held it in 7 quarters.
  • Bank Julius Baer & Co's Fate Therapeutics position peaked at $1.09M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2023.

Based on Bank Julius Baer & Co's 13F filing for Q3 2023, filed 13 Nov 2023.